Home
About Us
About us
Management Team
The Board of Directors
Investor & Media
Investor Relations Policy
News Releases
Financial Reports, Prospectus etc.
Stock Information & Financial Calendar
Presentations & Events
Corporate Documents
Q&A
Our Science & DRP® technology
Our Intellectual Property
Merger with MPI
Pipeline
Pipeline
APO010
Irofulven
LiPlaCis
2X-111
2X-121
2X-131
TK inhibitor
Scientific publications
Contact
中文页面
关于我们 (About us)
我们的技术与方案 (Our science and methods)
我们的管理团队 (Our management team)
董事会 (The Board of Directors)
News Releases
Latest news
Fetching…
Please enable JavaScript to load news.
